A carregar...
Gemcitabine plus S-1 for metastatic pancreatic cancer
To investigate the treatment effects of gemcitabine plus S-1 (GS) for metastatic pancreatic cancer in our institution. Data from 41 patients with metastatic pancreatic cancer treated with GS regimen in West China Hospital, Sichuan University were reviewed. The therapeutic efficacy and toxicity were...
Na minha lista:
| Publicado no: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer Health
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6203537/ https://ncbi.nlm.nih.gov/pubmed/30313120 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000012836 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|